These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 367086)

  • 1. Effect of oral verapamil on ventricular irregularity in long-standing atrial fibrillation.
    Khalsa A; Olsson B; Henriksson BA
    Acta Med Scand; 1979; 205(1-2):39-47. PubMed ID: 367086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Verapamil-induced ventricular regularity in atrial fibrillation. Effects of exercise, isoproterenol, atropine and conversion to sinus rhythm.
    Khalsa A; Olsson SB
    Acta Med Scand; 1979; 205(6):509-15. PubMed ID: 452946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term oral treatment with high doses of verapamil in lone atrial fibrillation.
    Johansson PA; Olsson SB
    Clin Cardiol; 1984 Mar; 7(3):163-70. PubMed ID: 6705301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical use of oral verapamil in chronic and paroxysmal atrial fibrillation.
    Stern EH; Pitchon R; King BD; Guerrero J; Schneider RR; Wiener I
    Chest; 1982 Mar; 81(3):308-11. PubMed ID: 7056105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute and chronic pharmacodynamic interaction of verapamil and digoxin in atrial fibrillation.
    Schwartz JB; Keefe D; Kates RE; Kirsten E; Harrison DC
    Circulation; 1982 Jun; 65(6):1163-70. PubMed ID: 7074776
    [No Abstract]   [Full Text] [Related]  

  • 6. Superiority of oral verapamil therapy to digoxin in treatment of chronic atrial fibrillation.
    Lang R; Klein HO; Weiss E; David D; Sareli P; Levy A; Guerrero J; Di Segni E; Kaplinsky E
    Chest; 1983 Mar; 83(3):491-9. PubMed ID: 6337787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disposition and pharmacologic effects of R/S-verapamil in patients with chronic atrial fibrillation: an investigation comparing single and multiple dosing.
    Busse D; Fromm MF; Mörike K; Drescher S; Kühlkamp V; Eichelbaum M
    Clin Pharmacol Ther; 2001 May; 69(5):324-32. PubMed ID: 11372000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of supraventricular arrhythmias with intravenous and oral verapamil.
    Gonzalez R; Scheinman MM
    Chest; 1981 Oct; 80(4):465-70. PubMed ID: 7023864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relative efficacy of oral verapamil and digoxin alone and in combination for the treatment of patients with chronic atrial fibrillation.
    Pomfret SM; Beasley CR; Challenor V; Holgate ST
    Clin Sci (Lond); 1988 Apr; 74(4):351-7. PubMed ID: 3281786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atrial fibrillation and flutter. Immediate control and conversion with intravenously administered verapamil.
    Tommaso C; McDonough T; Parker M; Talano JV
    Arch Intern Med; 1983 May; 143(5):877-81. PubMed ID: 6679229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Near doubling of heart rate after intravenous verapamil for treatment of atrial fibrillation without preexcitation.
    Orlov YS; Brodsky MA; Orlov MV; Allen B
    Pacing Clin Electrophysiol; 1997 Nov; 20(11):2867-9. PubMed ID: 9392821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The efficacy of sublingual verapamil in controlling rapid ventricular rate in chronic atrial fibrillation.
    Incze A; Frigy A; Cotoi S
    Rom J Intern Med; 1998; 36(3-4):219-25. PubMed ID: 10822518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of paroxysmal supraventricular tachycardia and tachyarrhythmia with verapamil].
    Penkov N; Penev A; Kaponov Kh
    Vutr Boles; 1984; 23(1):63-9. PubMed ID: 6730453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of intravenous verapamil on cardiac arrhythmias and on the electrocardiogram.
    Heng MK; Singh BN; Roche AH; Norris RM; Mercer CJ
    Am Heart J; 1975 Oct; 90(4):487-98. PubMed ID: 1163442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness and safety of oral verapamil to control exercise-induced tachycardia in patients with atrial fibrillation receiving digitalis.
    Panidis IP; Morganroth J; Baessler C
    Am J Cardiol; 1983 Dec; 52(10):1197-201. PubMed ID: 6359848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rate-control drugs affect variability and irregularity measures of RR intervals in patients with permanent atrial fibrillation.
    Corino VD; Ulimoen SR; Enger S; Mainardi LT; Tveit A; Platonov PG
    J Cardiovasc Electrophysiol; 2015 Feb; 26(2):137-41. PubMed ID: 25367150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Esmolol versus verapamil in the acute treatment of atrial fibrillation or atrial flutter.
    Platia EV; Michelson EL; Porterfield JK; Das G
    Am J Cardiol; 1989 Apr; 63(13):925-9. PubMed ID: 2564725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacologic management of atrial fibrillation: current therapeutic strategies.
    Lévy S
    Am Heart J; 2001 Feb; 141(2 Suppl):S15-21. PubMed ID: 11174354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Conversion rate and prevention of recurrence of paroxysmal and sustained atrial fibrillation or atrial flutter with verapamil/quinidine].
    Trappe HJ; Pfitzner P
    Med Klin (Munich); 1996 Oct; 91(10):617-25. PubMed ID: 9019638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Combination of quinidine and verapamil in auricular fibrillation].
    Sobrino JA; Maté I; Calvo L; Plaza I; Rico J; Moreno I; Mesa JM
    Rev Esp Cardiol; 1989 Apr; 42(4):262-6. PubMed ID: 2781120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.